Jianmeng Zhou, Fang Yi, Feng Wu, Pusheng Xu, Meihua Chen, Huahao Shen, Lin Lin, Yunhui Zhang, Suyun Li, Changgui Wu, Yadong Yuan, Gang Wang, Xianwei Ye, Ping Zhang, Huaping Tang, Qianli Ma, Lanqing Huang, Zhongmin Qiu, Haiyan Deng, Chen Qiu, Guochao Shi, Jiayu Pan, Wei Luo, Kian Fan Chung, the CPA Cohort Study Group…
Dear colleague, As a founding partner of the International Respiratory Coalition (IRC), the European Respiratory Society is pleased to share the new Lung Facts resource with you – now available on the official IRC…
Research – Open Access Fangyuan Li, Xuechen Wang, Shen Shen, Kai Huang, Ming Wang, Xiaofang Liu, Chengshuo Wang, Jianmin Jin & Luo Zhang BMC Pulmonary Medicine volume 22, Article number: 338 (2022) Abstract Background Although 20–60% of patients with chronic rhinosinusitis with nasal polyps…
Meghan D. Althoff, Guillermo Jimenez, Ryan Peterson, Ying Jin, Hartmut Grasemann, Sunita Sharma, Alex D. Federman, Juan P. Wisnivesky & Fernando Holguin Respiratory Research volume 23, Article number: 230 (2022) Abstract Background Imbalance in L-arginine and nitric oxide (NO) metabolism has been implicated in…
Joanne E. Kavanagh, Andrew P. Hearn, David J. Jackson Breathe 2021 17: 210144; DOI: 10.1183/20734735.0144-2021 Abstract There are now several monoclonal antibody (mAb) therapies (“biologics”) available to treat severe asthma. Omalizumab is an anti-IgE mAb and is licensed in severe…
Ariangela J Kozik, Fernando Holguin, Leopoldo N Segal, Talal A Chatila, Anne E Dixon, James E Gern, Catherine Lozupone, Nicholas Lukacs, Carey Lumeng, Philip L Molyneaux, Nichole Reisdorph, Ivan Vujkovic-Cvijin, Alkis Togias, Yvonne J Huang Am J Respir Cell Mol Biol. 2022 Aug;67(2):155-163. Abstract…
Bender B, Oppenheimer J, George M, Brown R, Patel A, Hill T, Boe A, Herrera EM, Dotiwala Z, Casciano J, Bernstein JA. Assessment of real-world escalation to biologics in US…
Oppenheimer J, Hoyte FCL, Phipatanakul W, Silver J, Howarth P, Lugogo NL. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma…
Phenotype-directed mepolizumab therapy reduced the number of asthma exacerbations among children and adolescents with exacerbation-prone eosinophilic asthma who live in disadvantaged urban neighborhoods, researchers reported in The Lancet. “[I]n urban children…
Articles Predictors of Outpatient Follow-Up Care after Adult Emergency Department Asthma Visits and Association with 30-Day OutcomesEthan E Abbott, Carmen Vargas-Torres, Sophie Karwoska Kligler, Sophia Spadafore & Michelle P. LinPages:…